Guerbet Korea
- Address: 10, Teheran-ro 38-gil, Gangnam-gu, Seoul, Republic of Korea
- Website: korea.guerbet.com/ko-kr
Guerbet Korea is the Korean subsidiary of the Guerbet Group, established in 1998.
Representative products offered by Guerbet Korea include Dotarem, an MRI contrast agent; Xenetix, an X-ray contrast agent; and Lipiodol, the worlds first iodinated contrast agent developed by Marcel Guerbet in 1901.
Through the supply of world-class pharmaceutical products, Guerbet Korea strives to firmly establish itself as a highly trusted specialty pharmaceutical company.
We remain committed to contributing to public health and to the advancement of the field of radiology in Korea by remembering that continuous efforts in research and development, as well as a passion for producing the worlds finest pharmaceuticals, are at the core of Guerbet's mission.
Representative products offered by Guerbet Korea include Dotarem, an MRI contrast agent; Xenetix, an X-ray contrast agent; and Lipiodol, the worlds first iodinated contrast agent developed by Marcel Guerbet in 1901.
Through the supply of world-class pharmaceutical products, Guerbet Korea strives to firmly establish itself as a highly trusted specialty pharmaceutical company.
We remain committed to contributing to public health and to the advancement of the field of radiology in Korea by remembering that continuous efforts in research and development, as well as a passion for producing the worlds finest pharmaceuticals, are at the core of Guerbet's mission.